ClinicalTrials.Veeva

Menu

Highly Cross-linked Polyethylene in Total Knee Arthroplasty

Ewha Womans University logo

Ewha Womans University

Status and phase

Completed
Phase 4

Conditions

Knee Arthroplasty, Total

Treatments

Procedure: Total knee arthroplasty with HXLPE liner
Procedure: Total knee arthroplasty with conventional polyethylene liner

Study type

Interventional

Funder types

Other

Identifiers

NCT03622398
XPEPETKA

Details and patient eligibility

About

The aim of this study was to determine clinical and radiographic results after posterior cruciate-substituting total knee arthroplasties with highly cross-linked polyethylene in one knee and compression mold conventional polyethylene in the contralateral knee in the same patients.

Enrollment

125 patients

Sex

All

Ages

20 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Younger than 65 years old
  • with end stage knee arthritis bad enough for knee replacement

Exclusion criteria

  • inflammatory arthritis
  • combined foot and ankle disorders.
  • dementia
  • patient older than 65 years old.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

125 participants in 2 patient groups

HXLPE
Experimental group
Description:
This side of knee implanted with HXLPE(highly crosslinked polyethylene) liner while undergoing total knee arthroplasty. This group will receive the intervention, "Total knee arthroplasty with HXLPE liner".
Treatment:
Procedure: Total knee arthroplasty with HXLPE liner
Conventional
Active Comparator group
Description:
This side of knee implanted with conventional polyethylene while undergoing standard total knee arthroplasty. This group will receive the intervention, "Total knee arthroplasty with conventional polyethylene liner".
Treatment:
Procedure: Total knee arthroplasty with conventional polyethylene liner

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems